These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
811 related items for PubMed ID: 15668428
1. Predictors of cognitive dysfunction in patients with systemic lupus erythematosus. McLaurin EY, Holliday SL, Williams P, Brey RL. Neurology; 2005 Jan 25; 64(2):297-303. PubMed ID: 15668428 [Abstract] [Full Text] [Related]
2. Risk factors for thrombosis and primary thrombosis prevention in patients with systemic lupus erythematosus with or without antiphospholipid antibodies. Tektonidou MG, Laskari K, Panagiotakos DB, Moutsopoulos HM. Arthritis Rheum; 2009 Jan 15; 61(1):29-36. PubMed ID: 19116963 [Abstract] [Full Text] [Related]
3. General and specific factors associated with severity of cognitive impairment in systemic lupus erythematosus. Tomietto P, Annese V, D'agostini S, Venturini P, La Torre G, De Vita S, Ferraccioli GF. Arthritis Rheum; 2007 Dec 15; 57(8):1461-72. PubMed ID: 18050188 [Abstract] [Full Text] [Related]
4. Cognitive dysfunction in systemic lupus erythematosus. Emori A, Matsushima E, Aihara O, Ohta K, Koike R, Miyasaka N, Kato M. Psychiatry Clin Neurosci; 2005 Oct 15; 59(5):584-9. PubMed ID: 16194262 [Abstract] [Full Text] [Related]
5. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. Mok CC, Lau CS, Wong RW. J Rheumatol; 2001 Apr 15; 28(4):766-71. PubMed ID: 11327248 [Abstract] [Full Text] [Related]
6. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Harrison MJ, Ravdin LD, Lockshin MD. Arthritis Rheum; 2006 Aug 15; 54(8):2515-22. PubMed ID: 16868972 [Abstract] [Full Text] [Related]
7. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Mikdashi J, Handwerger B. Rheumatology (Oxford); 2004 Dec 15; 43(12):1555-60. PubMed ID: 15342927 [Abstract] [Full Text] [Related]
8. Depression, fatigue, and pain in systemic lupus erythematosus (SLE): relationship to the American College of Rheumatology SLE neuropsychological battery. Kozora E, Ellison MC, West S. Arthritis Rheum; 2006 Aug 15; 55(4):628-35. PubMed ID: 16874786 [Abstract] [Full Text] [Related]
9. Anti-NR2 glutamate receptor antibodies and cognitive function in systemic lupus erythematosus. Hanly JG, Robichaud J, Fisk JD. J Rheumatol; 2006 Aug 15; 33(8):1553-8. PubMed ID: 16881112 [Abstract] [Full Text] [Related]
10. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus. Vlachoyiannopoulos PG, Toya SP, Katsifis G, Zintzaras E, Tzioufas AG, Moutsopoulos HM. J Rheumatol; 2008 Sep 15; 35(9):1768-75. PubMed ID: 18634157 [Abstract] [Full Text] [Related]
11. Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. Magalhães MB, da Silva LM, Voltarelli JC, Donadi EA, Louzada-Junior P. Scand J Rheumatol; 2007 Sep 15; 36(6):442-7. PubMed ID: 18092265 [Abstract] [Full Text] [Related]
12. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Hanly JG, Hong C, Smith S, Fisk JD. Arthritis Rheum; 1999 Apr 15; 42(4):728-34. PubMed ID: 10211887 [Abstract] [Full Text] [Related]
13. The relationship of antiphospholipid antibodies to cognitive function in patients with systemic lupus erythematosus. Denburg SD, Carbotte RM, Ginsberg JS, Denburg JA. J Int Neuropsychol Soc; 1997 Jul 15; 3(4):377-86. PubMed ID: 9260447 [Abstract] [Full Text] [Related]
14. Pattern of neuropsychologic dysfunction in inactive systemic lupus erythematosus. Glanz BI, Slonim D, Urowitz MB, Gladman DD, Gough J, MacKinnon A. Neuropsychiatry Neuropsychol Behav Neurol; 1997 Oct 15; 10(4):232-8. PubMed ID: 9359119 [Abstract] [Full Text] [Related]
15. Cognitive and neurologic status in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. Kozora E, Arciniegas DB, Filley CM, West SG, Brown M, Miller D, Grimm A, Devore MD, Wingrove C, Zhang L. Arthritis Rheum; 2008 Nov 15; 59(11):1639-46. PubMed ID: 18975359 [Abstract] [Full Text] [Related]
16. The presence of anti-phosphatidylserine/prothrombin antibodies as risk factor for both arterial and venous thrombosis in patients with systemic lupus erythematosus. Nojima J, Iwatani Y, Suehisa E, Kuratsune H, Kanakura Y. Haematologica; 2006 May 15; 91(5):699-702. PubMed ID: 16627257 [Abstract] [Full Text] [Related]
17. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients. Zhang CY, Lu LJ, Li FH, Li HL, Gu YY, Chen SL, Bao CD. J Clin Rheumatol; 2009 Apr 15; 15(3):111-6. PubMed ID: 19300290 [Abstract] [Full Text] [Related]
18. Cognitive impairment in patients with systemic lupus erythematosus. Hanly JG, Fisk JD, Sherwood G, Jones E, Jones JV, Eastwood B. J Rheumatol; 1992 Apr 15; 19(4):562-7. PubMed ID: 1593578 [Abstract] [Full Text] [Related]
19. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome. Alpert D, Mandl LA, Erkan D, Yin W, Peerschke EI, Salmon JE. Ann Rheum Dis; 2008 Mar 15; 67(3):395-401. PubMed ID: 17644539 [Abstract] [Full Text] [Related]
20. Cognitive function in a systemic lupus erythematosus inception cohort. Petri M, Naqibuddin M, Carson KA, Sampedro M, Wallace DJ, Weisman MH, Holliday SL, Padilla PA, Brey RL. J Rheumatol; 2008 Sep 15; 35(9):1776-81. PubMed ID: 18634154 [Abstract] [Full Text] [Related] Page: [Next] [New Search]